FdaApplication
NDA 021204
Identifiers
- fda_app_no: NDA021204
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2000-12-22 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| STARLIX | NATEGLINIDE | 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| STARLIX | NATEGLINIDE | 60MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
2 products